Cargando…
COVID-19 induced ARDS, and the use of galantamine to activate the cholinergic anti-inflammatory pathway
Autor principal: | Ahmad, Farrukh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7536172/ https://www.ncbi.nlm.nih.gov/pubmed/33038588 http://dx.doi.org/10.1016/j.mehy.2020.110331 |
Ejemplares similares
-
The case of galantamine: repurposing and late blooming of a cholinergic drug
por: Mucke, Hermann AM
Publicado: (2015) -
Cholinergic anti-inflammatory pathway and COVID-19
por: Mehranfard, Danial, et al.
Publicado: (2022) -
Enhanced parasympathetic cholinergic activity with galantamine inhibited lipid-induced oxidative stress in obese African Americans
por: Parsa, Dena, et al.
Publicado: (2022) -
COVID-19-related myocarditis and cholinergic anti-inflammatory pathways
por: Liu, Weike, et al.
Publicado: (2021) -
The Cholinergic Drug Galantamine Alleviates Oxidative Stress Alongside Anti-inflammatory and Cardio-Metabolic Effects in Subjects With the Metabolic Syndrome in a Randomized Trial
por: Sangaleti, Carine Teles, et al.
Publicado: (2021)